Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhinoconjunctivitis, Allergic”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Testing effectiveness (Phase 2)Ended earlyNCT02297490
What this trial is testing

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Who this might be right for
Allergic RhinoconjunctivitisHealthy Volunteers
Allergopharma GmbH & Co. KG 158
Testing effectiveness (Phase 2)Study completedNCT02166268
What this trial is testing

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber

Who this might be right for
Grass Pollen Induced Allergic Rhinoconjunctivitis
ALK-Abelló A/S 140
Testing effectiveness (Phase 2)Study completedNCT00973453
What this trial is testing

Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 48
Large-scale testing (Phase 3)Study completedNCT00263601
What this trial is testing

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Grass Pollen Allergy
Allergopharma GmbH & Co. KG 154
Large-scale testing (Phase 3)Study completedNCT00135629
What this trial is testing

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Who this might be right for
Rhinitis, Allergic, Seasonal
Imperial College London 18
Testing effectiveness (Phase 2)UnknownNCT00247520
What this trial is testing

Safety and Efficacy Study of rEV131 in Allergic Rhinitis

Who this might be right for
Hay Fever
Evolutec Group 112
Early research (Phase 1)Study completedNCT02881879
What this trial is testing

Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites

Who this might be right for
Allergic Rhinoconjunctivitis
Roxall Medicina España S.A 43
Not applicableStudy completedNCT02488447
What this trial is testing

Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis

Who this might be right for
Allergic Rhinoconjunctivitis
Roxall Medicina España S.A 215
Large-scale testing (Phase 3)Study completedNCT01902992
What this trial is testing

Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch

Who this might be right for
Allergic Rhinoconjunctivitis
Novartis 202
Large-scale testing (Phase 3)Study completedNCT00227279
What this trial is testing

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Who this might be right for
Allergy
ALK-Abelló A/S 634
Testing effectiveness (Phase 2)Study completedNCT01166061
What this trial is testing

Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis

Who this might be right for
Allergy
Circassia Limited 50
Large-scale testing (Phase 3)Study completedNCT00418379
What this trial is testing

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Who this might be right for
Allergy
Stallergenes Greer 633
Early research (Phase 1)Study completedNCT00457444
What this trial is testing

Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration

Who this might be right for
Rhinoconjunctivitis
University of Zurich 35
Post-approval studies (Phase 4)Study completedNCT01854736
What this trial is testing

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

Who this might be right for
Allergic Rhinitis Due to Grass Pollens
ALK-Abelló A/S 51
Large-scale testing (Phase 3)Study completedNCT01731249
What this trial is testing

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Who this might be right for
HypersensitivityAllergic RhinitisAllergic Conjunctivitis+1 more
Stallergenes Greer 574
Large-scale testing (Phase 3)Study completedNCT00309062
What this trial is testing

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Birch Pollen Allergy
Allergopharma GmbH & Co. KG
Testing effectiveness (Phase 2)Study completedNCT01506375
What this trial is testing

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Who this might be right for
Hay Fever
BioTech Tools S.A. 24
Large-scale testing (Phase 3)Study completedNCT01694836
What this trial is testing

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Who this might be right for
Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent AsthmaSensitization Against Betula Alba (Birch) Pollen
Leti Pharma GmbH 634
Large-scale testing (Phase 3)Study completedNCT00504933
What this trial is testing

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Faes Farma, S.A. 683
Not applicableStudy completedNCT00411606
What this trial is testing

Normal Values of Facial Thermography

Who this might be right for
HealthyAllergyAllergic Rhinoconjunctivitis
West Penn Allegheny Health System 300
Load More Results